These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1252 related items for PubMed ID: 22106869
1. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, Lipton R. Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869 [Abstract] [Full Text] [Related]
2. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB, Serrano D, Pavlovic JM, Manack AN, Reed ML, Turkel CC, Buse DC. Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745 [Abstract] [Full Text] [Related]
3. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, Kosinski M. Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662 [Abstract] [Full Text] [Related]
4. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB. Value Health; 2013 Mar; 16(1):31-8. PubMed ID: 23337213 [Abstract] [Full Text] [Related]
5. Opioid use and dependence among persons with migraine: results of the AMPP study. Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB. Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775 [Abstract] [Full Text] [Related]
6. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Reed ML, Fanning KM, Serrano D, Buse DC, Lipton RB. Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833 [Abstract] [Full Text] [Related]
7. Depression and anxiety: effect on the migraine-obesity relationship. Tietjen GE, Peterlin BL, Brandes JL, Hafeez F, Hutchinson S, Martin VT, Dafer RM, Aurora SK, Stein MR, Herial NA, Utley C, White L, Khuder SA. Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537 [Abstract] [Full Text] [Related]
8. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB, Buse DC, Serrano D, Holland S, Reed ML. Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870 [Abstract] [Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R, Schreiber C. Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [Abstract] [Full Text] [Related]
10. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB. Headache; 2012 Jun; 52(10):1456-70. PubMed ID: 22830411 [Abstract] [Full Text] [Related]
11. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML. Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896 [Abstract] [Full Text] [Related]
12. Headache prevention outcome and body mass index. Bigal ME, Gironda M, Tepper SJ, Feleppa M, Rapoport AM, Sheftell FD, Lipton RB. Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246 [Abstract] [Full Text] [Related]
13. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB. Headache; 2015 Apr; 55(4):502-18. PubMed ID: 25881676 [Abstract] [Full Text] [Related]
14. A pivotal moment in 50 years of headache history: the first American Migraine Study. Tepper SJ. Headache; 2008 May; 48(5):730-1; discussion 732. PubMed ID: 18471125 [Abstract] [Full Text] [Related]
15. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB. Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386 [Abstract] [Full Text] [Related]
16. Allodynia in migraine: association with comorbid pain conditions. Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA. Headache; 2009 Oct; 49(9):1333-44. PubMed ID: 19788473 [Abstract] [Full Text] [Related]
17. Endometriosis is associated with prevalence of comorbid conditions in migraine. Tietjen GE, Bushnell CD, Herial NA, Utley C, White L, Hafeez F. Headache; 2007 Oct; 47(7):1069-78. PubMed ID: 17635599 [Abstract] [Full Text] [Related]
18. Migraine days decline with duration of illness in adolescents with transformed migraine. Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM, Lipton RB. Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034 [Abstract] [Full Text] [Related]
19. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB. Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857 [Abstract] [Full Text] [Related]
20. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM. Headache; 2011 Jun; 51(7):1058-77. PubMed ID: 21762134 [Abstract] [Full Text] [Related] Page: [Next] [New Search]